Citation:Li J, Qin S, Xu R, Yau TC, Ma B, Pan H, et al 2015

Citation

Li J, Qin S, Xu R, Yau TC, Ma B, Pan H, et al. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2015 Jun;16(6):619-29 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25981818.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Systemic options for third-line treatment